Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)Christopher Ma, Philip E. Putnam, Mirna Chehade et al.|Journal of Allergy and Clinical Immunology|2021Cited by 82
P0636 Impact of obefazimod treatment on histologic and combined histologic and endoscopic outcomes in patients with moderately to severely active ulcerative colitis: results from the Phase 2b open-label maintenance studyFernando Magro, Séverine Vermeire, Laurent Peyrin‐Biroulet et al.|Journal of Crohn s and Colitis|2025Cited by 1